|

Heart Disease Clinical Trials in New Orleans, LA

51 recruiting studies within 50 miles

Phase
Trial Phase Dist.
AN INTERNATIONAL, OBSERVATIONAL, BLINDED STUDY TO ASSESS THE PERFORMANCE OF THE CORDIO HEARO SYSTEM—<1 mi
The EMPOWER Trial - The Carillon Mitral Contour System® in Treating Heart Failure With FMRN/A<1 mi
Percutaneous or Surgical Repair In Mitral Prolapse And Regurgitation for ≥60 Year-olds (PRIMARY)N/A<1 mi
Effect of Dalcetrapib on CV Risk in a Genetically Defined Population With a Recent ACSPhase 3<1 mi
Sodium Lowering Vascular Effects TrialN/A<1 mi
A Randomized Comparison of Personalized Therapy Mgmt Based On Coronary Atherosclerotic Plaque Vs. Usual Care for Symptomatic Patients With Suspicion of CADN/A<1 mi
Inclisiran Versus Placebo for the Prevention of Major Adverse Cardiovascular and Limb Events in Patients Undergoing Percutaneous Coronary Intervention or Peripheral Endovascular InterventionPhase 4<1 mi
CORCYM Mitral, Aortic aNd Tricuspid Post-maRket Study in a reAl-world Setting—<1 mi
CTSN Embolic Protection TrialN/A<1 mi
Assessment of CCM in HF With Higher Ejection FractionN/A<1 mi
Anticoagulation in ICH Survivors for Stroke Prevention and RecoveryPhase 3<1 mi
Baseline Atrial Fibrosis Predicts Risk for Post-operative Atrial Fibrillation in Patients Undergoing Cardiac Surgery—<1 mi
National Collaborative to Improve Care of Children With Complex Congenital Heart Disease—<1 mi
Study to Evaluate the Effect of Balcinrenone/Dapagliflozin in Patients With Heart Failure and Impaired Kidney FunctionPhase 3<1 mi
LEVEL-2: LEVosimendan to Improve Exercise Limitation in Patients With PH-HFpEF-2Phase 3<1 mi
Trial Investigating the Efficacy and Safety of Weekly Lonapegsomatropin Compared to Daily Somatropin in Children and Adolescents With Short Stature or Growth Failure Due to Growth Hormone Sufficient DisordersPhase 3<1 mi
PROGRESS: Management of Moderate Aortic Stenosis by Clinical Surveillance or TAVRN/A<1 mi
Study With Omecamtiv Mecarbil (CK-1827452) to Treat Chronic Heart Failure With Severely Reduced Ejection FractionPhase 3<1 mi
The CoAGulation Biomarkers and Atrial Fibrillation (COAG-AF) Pilot Study—<1 mi
PPG to Predict Ejection Fraction and Other Echographic Data in the General Population—<1 mi
New Orleans Pulmonary Hypertension Biobank—<1 mi
Tulane iPredict, Prevent Study to Evaluate the Progression of Atrial Myopathy.—<1 mi
An Open Label Extension (OLE) Study (Following Completion of CTQJ230A12301) to Evaluate Long-term Safety and Tolerability of Pelacarsen (TQJ230)Phase 3<1 mi
The Fourth Left Atrial Appendage Occlusion StudyN/A<1 mi
Anticoagulation for New-Onset Post-Operative Atrial Fibrillation After CABGPhase 3<1 mi
A Research Study to Look at How Ziltivekimab Works Compared to Placebo in People With Heart Failure and InflammationPhase 3<1 mi
Health Electronic Assessment of Risks and Trends Using Biometric Equipment and Technology—<1 mi
Ultra-Low Contrast Angiography in AKIPhase 3<1 mi
Effects of Dexrazoxane Hydrochloride on Biomarkers Associated With Cardiomyopathy and Heart Failure After Cancer Treatment—<1 mi
Product Surveillance Registry—<1 mi
PARTNER 3 Trial - Aortic Valve-in-ValveN/A<1 mi
Atrial Fibrosis in Obstructive Sleep Apnea Patients: A Pilot StudyN/A<1 mi
CAPTURE-2: Controlled Arterial Protection to Ultimately Remove Embolic MaterialN/A<1 mi
Edwards PASCAL Transcatheter Valve Repair System Pivotal Clinical TrialN/A<1 mi
Pharmacokinetics, Pharmacodynamics, and Safety Profile of Understudied Drugs Administered to Children Per Standard of Care (POPS)—<1 mi
S1501 Dual Observational and Randomized Cohort Study of Patients With Metastatic HER-2+ Breast Cancer at Risk of Cardiac ToxicityPhase 3<1 mi
AngelMed Guardian® System PMA Post Approval Study—28 mi
Maridebart Cafraglutide in Heart Failure With Preserved or Mildly Reduced Ejection Fraction and ObesityPhase 328 mi
A Study to Test Whether Vicadrostat in Combination With Empagliflozin Helps People With Heart FailurePhase 328 mi
OCEAN(a)-PreEvent - Olpasiran Trials of Cardiovascular Events And LipoproteiN(a) Reduction to Prevent First Major Cardiovascular EventsPhase 328 mi
AMBER-HFpEF: Assessment of CK-4021586 in a Multi-Center, Blinded Evaluation of Safety and Tolerability Results in HFpEFPhase 228 mi
A Study to Test Whether Vicadrostat (BI 690517) in Combination With Empagliflozin Helps People With Heart Failure and a Weak Pumping Function of the Left Side of the HeartPhase 345 mi
A Study to Determine the Efficacy and Safety of Finerenone on Morbidity and Mortality Among Hospitalized Heart Failure PatientsPhase 345 mi
AltaValve Pivotal TrialN/A46 mi
SELUTION 4 De Novo Small Vessel IDE TrialN/A46 mi
Clinical Evaluation of the AccuCinch® Ventricular Restoration System in Patients Who Present With Symptomatic Heart Failure With Reduced Ejection Fraction (HFrEF): The CORCINCH-HF StudyN/A46 mi
J-Valve Transfemoral Pivotal StudyN/A46 mi
ELEVATE-HFpEF Clinical StudyN/A46 mi
Efficacy of the COronary SInus Reducer in Patients With Refractory Angina IIN/A46 mi
The CONFORM Pivotal TrialN/A46 mi
TRIcvalve biCAVal Valve System for Severe Tricuspid Regurgitation (TRICAV-I)N/A46 mi

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.